Business Credit Business Travel Franchising Personal Finance Sales & Selling Technology Women in Business Careers E-Commerce & Internet Finance & Accounting Labor & Employment Management Marketing & Advertising Operations Starting a Business > See All

by Title A-H by Title I-P by Title Q-Z > See All

Business Intelligence Small Business Blog Business Planning E-Commerce & Internet Finance & Accounting Home-Based Business Human Resources & Employment Management & Leadership Marketing & Advertising Operations Sales Technology Women in Business > See All

Hiring & Firing Intellectual Property Internet & Technology Legal Mergers & Acquisitions Money & Fundraising Real Estate/Landlord-Tenant Sales & Marketing Starting a Business Business Guides Forms Kits > See All

Construction Medical Practices Restaurants Retail Trade Manufacturing Real Estate Wholesale Trade > See All

Accounting Advertising & Marketing Computers & Software Financial Services Human Resources Internet & Online Management Small Business > See All

Business Exchange Business Answers Buyer's Guides Franchise Opportunities Glossary Trials & Downloads Partner Resources Podcast Library Quote Center Video Library Web Site Tools > See All

Multimedia Available: U.S. FDA Approves FUZEON; First Drug to Block Entry of HIV into Immune...

Publication: Business Wire
Date: Friday, March 14 2003

Business Editors/Health/Medical Writers

ADVISORY...for Friday (March 14)

NOTE TO EDITORS: Multimedia Assets Available With This Story

Include Text News Releases, Video

--(BUSINESS WIRE)

The Food and Drug administration has approved FUZEON (enfuvirtide), the

first drug to block entry of HIV into immune cells. Unlike all currently approved anti-HIV drugs, FUZEON(tm) blocks the virus from entering the human immune cell, preventing HIV replication that can devastate the immune systems of HIV infected individuals. By contrast, all other classes of HIV drugs work after HIV has entered the cell and begun its replication process.

You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?8831

This multimedia news story is for free and unrestricted use on your news information site (and for print or broadcast too). Visit http://www.newstream.com to download video, audio, text, graphics, and photos.

If you have any questions about the story, or about Newstream.com, please write to us at info@newstream.com.

In addition, make sure to read these articles:

Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA.

First in a New Class of Oral HIV Medicines in More Than a Decade NEW YORK -- Pfizer Inc announced today that the U.S. Food ......

Newstream.com Digest: New AIDS Drug FUZEON Wins FDA Approval, Yahoo! Unveils Premium...

Entertainment Editors/Business Editors/High-Tech Writers NEW YORK--(BUSINESS WIRE)--March 17, 2003 U.S. FDA Approves FUZEON(tm); First Drug to Block Entry of HIV into Immune Cells The Food ......

Geron Presents Data On HIV/AIDS Drug Candidate at the XVI International AIDS Conference.

MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN) announced today the presentation of new data supporting the development of TAT0002, a small molecule telomerase activator ......

BIOPULSE INTERNATIONAL INC.

South Jordan -- BIOPULSE INTERNATIONAL INC. announced the acquisition of the exclusive intellectual property rights to clinical applications of MFGC, a preparation created from a ......

Mutant gene delays AIDS progression by 2-4 years.

FREDERICK, Md. - Researchers here at the National Cancer Institute found that a mutation on the CCR2 gene can delay the progression of AIDS for ......

Accelerated Aging of Immune Cells Linked to Exhaustion of Immune Response in Patients with...

MENLO PARK, Calif.--(BUSINESS WIRE)--June 27, 1996--Research focused on a key marker of cell replication demonstrates that the immune cells of HIV-infected patients age at an ......

Medistem Reports Novel Method of Immunomodulation Through Genetic Reprogramming of Immune...

SCOTTSDALE, Ariz. -- Medistem Laboratories, Inc. (OTCBB:MDSM), committed to the ethical development of next-generation medical therapies from non-controversial adult stem cell sources, announced today ......

Using MRI to track immune cells may detect pending heart rejection episode.

A new tool using magnetic resonance imaging (MRI) to track immune cells as they infiltrate a transplanted heart in the early stages of rejection could ......

Incyte Begins Phase I Study of New HIV Drug in Healthy Volunteers.

WILMINGTON, Del. -- Incyte Corporation (Nasdaq:INCY) today announced that it has initiated a Phase I clinical trial of INCB9471, a new orally available CCR5 ......

Genetically altered dendritic cells can improve body's acceptance of transplanted tissues,...

Genetically altered dendritic cells (DCs) could appreciably improve the body's acceptance of transplanted tissues, according to a report presented by University of Pittsburgh (Pitt) researchers ......

Praxis Pharmaceuticals acquires patent rights to new drugs for treating organ transplant...

Praxis Pharmaceuticals, Inc., Vancouver, British Columbia, announced it has acquired three new patents for drugs being developed to treat solid organ transplant rejection. The patents-US ......

'Underappreciated' Immune Cells May Play Important Role in Progression of Type 1 Diabetes,...

Health/Medical Writers BOSTON--(BUSINESS WIRE)--May 24, 2004 A study reported in the May issue of the Proceedings of the National Academy of Sciences suggests that cells ......

T T T

Digg It

del.icio.us

Related Resources

Conference highlights.

The Annual Retrovirus Conference is the major HIV research meeting in the US. Each year, several thousand healthcare providers, researchers, and community activists meet for ......

Inhibition of HIV Fusion: Challenges for Correctional Health Care

Authors' Note: The opinions expressed herein are solely those of the authors and do not reflect those of the Health Resources and Services Administration, the ......

Getting high may damage the immune system. (Bottom Lines).

A study of specially bred mice transplanted with human immune cells has shown that cocaine increases the production and spread of HIV. Mice given cocaine ......

Multimedia Available: U.S. FDA Approves FUZEON; First Drug to Block Entry of HIV into Immune...

In addition, make sure to read these articles:

Related Resources

Related Articles

Business Resources

Sponsored Links